RE:RE:Q2I've said it before and I'll say it again. This thing has a place in my retirement account and I'm looking at the long term on this one.
As various product segements continue to be proven, internationally, it will become much easier to sell what is rapidly becoming a proven technology.
In the longer term the royalty revenue stream will provide stability and may support a decent dividend model if management goes in that direction (it was mentioned as a possibility at one point).
Either way with patented techology, several thriving product segments, and a few quarters of profits in the bag the long term risk/reward model is looking pretty good at this point. And, of course, there is always the possibility that the pharmaceutical industry will start to develop also.